KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 171 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 2.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $489,000 | -32.0% | 46,472 | 0.0% | 0.01% | -28.6% |
| Q4 2020 | $719,000 | +90.2% | 46,472 | +79.4% | 0.01% | +75.0% |
| Q3 2020 | $378,000 | -23.0% | 25,900 | 0.0% | 0.00% | -33.3% |
| Q2 2020 | $491,000 | -1.4% | 25,900 | 0.0% | 0.01% | -14.3% |
| Q1 2020 | $498,000 | +39.1% | 25,900 | +38.5% | 0.01% | +75.0% |
| Q4 2019 | $358,000 | +98.9% | 18,700 | 0.0% | 0.00% | +100.0% |
| Q3 2019 | $180,000 | +60.7% | 18,700 | 0.0% | 0.00% | +100.0% |
| Q2 2019 | $112,000 | +2.8% | 18,700 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $109,000 | -37.7% | 18,700 | 0.0% | 0.00% | -50.0% |
| Q4 2018 | $175,000 | -45.0% | 18,700 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $318,000 | 0.0% | 18,700 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $318,000 | – | 18,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 3,561,052 | $26,245,000 | 5.86% |
| Palo Alto Investors LP | 5,621,533 | $41,431,000 | 3.20% |
| Iron Triangle Partners LP | 2,000,000 | $14,740,000 | 1.75% |
| Altium Capital Management LP | 645,000 | $4,754,000 | 1.59% |
| Birchview Capital, LP | 269,332 | $1,985,000 | 1.43% |
| Rubric Capital Management LP | 3,607,443 | $26,587,000 | 0.96% |
| Lombard Odier Asset Management (Switzerland) SA | 776,053 | $5,720,000 | 0.45% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,344,929 | $9,912,000 | 0.40% |
| Golden State Equity Partners | 41,850 | $308,000 | 0.16% |
| Hennion & Walsh Asset Management, Inc. | 385,837 | $2,844,000 | 0.15% |